Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Esophageal Neoplasms × Ropivacaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 11 Pain, Postoperative 8 Prostatic Neoplasms 4 Pain 4 Agnosia 4 Stomach Neoplasms 3 Lung Neoplasms 3 Postoperative Complications 2 Neoplasms 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Supratentorial Neoplasms 1 Sleep Deprivation 1 Sarcoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Cysts 1 Neuroblastoma 1 Neoplasm Metastasis 1 Meningioma 1 Malignant Neoplasms of Male Genital Organs 1 Intraoperative Complications 1 Goiter 1 Ganglion Cysts 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Emergence Delirium 1 Chronic Pain 1

Interventions

Cisplatin 85 Fluorouracil 70 Radiotherapy 59 Paclitaxel 53 Docetaxel 46 Oxaliplatin 44 Irinotecan 39 Leucovorin 31 Capecitabine 28 Carboplatin 21 Surgical Procedures, Operative 19 Radiation 18 Esophagectomy 18 Bevacizumab 15 pembrolizumab 13 Neoadjuvant Therapy 13 Cetuximab 13 Epirubicin 10 Drug Therapy 10 S 1 (combination) 8 Magnetic Resonance Spectroscopy 8 Gemcitabine 8 Chemotherapy, Adjuvant 8 Trastuzumab 7 Erlotinib Hydrochloride 7 Surveys and Questionnaires 6 Panitumumab 6 Nivolumab 6 Chemoradiotherapy 6 Albumin-Bound Paclitaxel 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03185403 2017-06-14

HEMOBLOC

University Hospital, Lille

Phase NA Completed

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡